We recently published an article titled 9 High Growth Canadian Stocks to Buy. In this article, we are going to take a look at ...

CRON's financials show strong liquidity with a sequential increase in cash and cash equivalents, no debt, and positive free cash flow. Despite unprofitability, CRON's assets dwarf liabilities, and it ...

The average one-year price target for Cronos Group (NasdaqGM:CRON) has been revised to $3.62 / share. This is an increase of 104.89% from the prior estimate of $1.77 dated June 20, 2025. The price ...

We came across a bullish thesis on Cronos Group Inc. (CRON) on Substack by Jake LaMotta. In this article, we will summarize the bulls’ thesis on CRON. Cronos Group Inc. (CRON)’s share was trading at ...

Fintel reports that on December 9, 2025, ROTH CAPITAL PARTNERS maintained coverage of Cronos Group (NasdaqGM:CRON) with a Buy recommendation. Analyst Price Forecast Suggests 11.27% Upside As of ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cronos Group (CRON) is a stock that can certainly grab the ...

Cronos Group Inc CRON shares are trading higher by 10.6% to $2.07 Thursday afternoon on upward momentum and amid strength in the broader cannabis sector. Shares of cannabis stocks and ETFs are trading ...

This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 Promising SmallCap Stocks Under $1 Billion ...